Amphista TherapeuticsListed
No domain yetbiotech_life_sciences
Amphista Therapeutics is a UK-based biotech company focused on targeted protein degradation to develop new treatments for diseases. The company aims to create first-class therapeu…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Amphista Therapeutics is a UK-based biotech company focused on targeted protein degradation to develop new treatments for diseases. The company aims to create first-class therapeu…
Anaveon is a late stage preclinical biotech company focused on developing engineered antibodies that target central regulatory nodes of the immune system to treat autoimmune disea…
Aravax is a clinical stage biotechnology company dedicated to revolutionising the treatment of food allergies with next-generation, disease-modifying immunotherapies which are saf…
Artios Pharma is focused on developing innovative therapies for cancer treatment through its proprietary DNA Damage Response (DDR) platform.
Biopharmaceutical company developing precision therapies for cardiac arrhythmias, including arrhythmogenic right ventricular cardiomyopathy (ARVC), cardiac sarcoidosis, and post-C…
AstronauTx Ltd is a biotech company focused on developing treatments for Alzheimer's disease and other neurodegenerative disorders by improving sleep architecture.
Atalanta is a mathematical AI company that brings speed and rigor to the design, implementation, and verification of complex systems. Their platform, Argo, helps various sectors i…
Averna Therapeutics, Inc. is a biotechnology company developing novel genomic medicines based on gene insertion technology.
CatalYm is pioneering the neutralization of GDF-15 to overcome cancer therapy resistance, developing safe and efficacious immune therapies for solid tumors, particularly focusing…
Citryll is a biotech company developing innovative therapies for immune-mediated inflammatory diseases by targeting Extracellular Traps. It raised EUR 85 million in Series B fundi…
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
Biotechnology company developing bispecific extracellular protein degraders that selectively direct target degradation to disease tissues, with oncology applications.
Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeuti…
Fore Biotherapeutics is a precision oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers.
FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers.
GentiBio is a biotechnology company specializing in engineered regulatory T cells (Tregs) to treat autoimmune, alloimmune, and inflammatory diseases. Their proprietary platform en…
Granite Bio is a biotechnology company developing first-in-class antibodies targeting the root causes of inflammatory, autoimmune, and fibrotic diseases.
Biotechnology company developing precision covalent medicines using a proprietary chemoproteomics discovery platform. The platform maps histidine-, tyrosine-, and lysine-based bin…
Cambridge-based biotechnology company developing structure-based, oral small-molecule somatic expansion inhibitors for Huntington’s disease and other triplet repeat expansion dise…
Mediar Therapeutics is pioneering a novel approach to fibrosis treatment by disabling the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progress…
NRG Therapeutics is an innovative, clinical stage neuroscience drug discovery company focused on developing transformative treatments for neurodegenerative diseases such as ALS an…
Clinical-stage biopharmaceutical company developing first-in-class therapeutics to protect retinal cells and preserve vision in retinal diseases. Its lead candidate, xelafaslatide…
Protego Health develops software for healthcare revenue cycle management focused on reducing medical claim denials. The platform integrates payer-specific policies and coding guid…
RhyGaze AG is focused on gene therapy for vision restoration, utilizing optogenetic proteins and gene therapy tools to restore sight for individuals with vision loss due to retina…
Biotechnology company developing antibodies that selectively target TNF and other TNF superfamily members. Its approach aims to improve the benefit-risk profile of TNF-targeting t…
SeaWolf specializes in producing high-impact videos for products, prototypes, and environments where traditional filming isn’t possible. They transform technical drawings into hyp…
Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates (ADCs) that expand the therapeutic window for patients with difficult to treat can…
SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. The company utilizes its proprietary Pr…
Tagworks Pharmaceuticals is pioneering Click-to-Release technology to enhance the efficacy and safety of systemic therapies for cancer treatment, focusing on antibody-drug conjuga…
Paris-based biotechnology company developing gene therapy treatments for orphan diseases, with a focus on liver-targeted therapies that correct malfunctioning genes. Its pipeline…
Kynexis is advancing a potential first-in-class approach to restore cognitive function for people living with brain diseases. The company is developing KYN-5356, a first-in-class…